Sarepta Therapeutics, Inc. (SRPT)
16.96
-0.16
(-0.93%)
USD |
NASDAQ |
May 21, 16:00
17.09
+0.13
(+0.77%)
After-Hours: 19:59
Sarepta Therapeutics Research and Development Expense (TTM) : 896.74M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| PTC Therapeutics, Inc. | 447.15M |
| Keros Therapeutics, Inc. | 96.95M |
| REGENXBIO, Inc. | 217.03M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |
| Cytokinetics, Inc. | 400.51M |